Fig. 6From: M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patientsThe correlation between the cluster and immunotherapy response: the correlation of the TIDE score and the clusters (A), TCGA patients with/without immunotherapy response between the clusters (B), cluster plot showing two distinct groups in the IMvigor210 cohort (C), IMvigor210 patients with/without immunotherapy response in the clusters (D). Chemotherapy response (J). IC50: half-maximal inhibitory concentration, CR: complete response, PR: partial response, SD: stable disease, PD: progressive disease. nsP ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001Back to article page